WILD TYPE ATTR AMYLOIDOSIS
Clinical trials for WILD TYPE ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new WILD TYPE ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for WILD TYPE ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug ease nerve pain in rare heart disease?
Disease control CompletedThis study tested the drug patisiran in 10 adults with a rare condition called ATTR amyloidosis that causes nerve damage. Participants received an IV infusion every 21 days for 24 months. Researchers measured changes in nerve function, autonomic symptoms, and quality of life to s…
Matched conditions: WILD TYPE ATTR AMYLOIDOSIS
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could your lifetime workout routine protect your heart?
Knowledge-focused CompletedThis study looked at whether being physically active over a lifetime is linked to developing a rare heart disease called wild-type transthyretin amyloid cardiomyopathy. Researchers compared the exercise histories of 180 people over age 60, including those with the disease, those …
Matched conditions: WILD TYPE ATTR AMYLOIDOSIS
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC